// App-Quantinova.ai

PO1919 : Clinical Outcomes in Lupus Nephritis by Renal Response Status: A Retrospective Analysis of the Hopkins Lupus Cohort

Researchers

Presenter

  • Petri Michelle

Principal Investigators

  • Fu Qinggong

  • Green Yulia

  • Madan Anuradha

  • Goldman DanielW

  • Cooper-Blenkinsopp Selin

Medical Centers

  • John Hopkins University, Baltimore, Maryland, United States

  • GlaxoSmithKline Upper Providence Pennsylvania United States

  • GlaxoSmithKline, Uxbridge, United Kingdom

  • GSK, Collegeville, Pennsylvania, United States

  • GlaxoSmithKline, Stevenage, United Kingdom.

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Microvascular complications of diabetes 1

  • Renal insufficiency

  • Lupus nephritis

  • Renal disease

  • Nephritis

  • Lupus

  • End stage renal disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved